Invention Grant
- Patent Title: Anti-LPS enriched immunoglobulin for use in treatment and/or prophylaxis of fibrosis
-
Application No.: US15033485Application Date: 2014-10-29
-
Publication No.: US10464998B2Publication Date: 2019-11-05
- Inventor: Yaron Ilan , Meir Mizrahi
- Applicant: HADASIT MEDICAL RESEARCH SERVICES AND DEVELOPMENT LIMITED
- Applicant Address: IL Jerusalem
- Assignee: HADASIT MEDICAL RESEARCH SERVICES AND DEVELOPMENT LIMITED
- Current Assignee: HADASIT MEDICAL RESEARCH SERVICES AND DEVELOPMENT LIMITED
- Current Assignee Address: IL Jerusalem
- Agency: Browdy and Neimark, PLLC
- Priority: AU2013904191 20131030
- International Application: PCT/IB2014/065676 WO 20141029
- International Announcement: WO2015/063693 WO 20150507
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/12 ; A61K35/20 ; G01N33/68 ; G01N33/52 ; A61K39/00
Abstract:
This invention relates to methods and compositions for treating fibrosis, by administering compositions comprising anti-LPS immunoglobulin enriched colostrum preparations. In particular, the invention relates to methods and compositions for the treatment of liver fibrosis and/or lung fibrosis. Prophylactic or therapeutic compositions and diagnostic methods are also disclosed and claimed.
Public/Granted literature
- US20160251414A1 ANTI-LPS ENRICHED IMMUNOGLOBULIN FOR USE IN TREATMENT AND/OR PROPHYLAXIS OF FIBROSIS Public/Granted day:2016-09-01
Information query
